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Defective mitochondrial fission 
augments NLRP3 inflammasome 
activation
Sangjun Park1, Ji-Hee Won1, Inhwa Hwang1, Sujeong Hong1, Heung Kyu Lee2 & Je-Wook Yu1
Despite the fact that deregulated NLRP3 inflammasome activation contributes to the pathogenesis 
of chronic inflammatory or metabolic disorders, the underlying mechanism by which NLRP3 
inflammasome signaling is initiated or potentiated remains poorly understood. Much attention is 
being paid to mitochondria as a regulator of NLRP3 inflammasome activation, but little is known 
about the role of mitochondrial dynamics for the inflammasome pathway. Here, we present evidence 
that aberrant mitochondrial elongation caused by the knockdown of dynamin-related protein 1 
(Drp1) lead to a marked increase in NLRP3-dependent caspase-1 activation and interleukin-1-beta 
secretion in mouse bone marrow-derived macrophages. Conversely, carbonyl cyanide m-chlorophenyl 
hydrazone, a chemical inducer of mitochondrial fission, clearly attenuated NLRP3 inflammasome 
assembly and activation. Augmented activation of NLRP3 inflammasome by mitochondrial 
elongation is not resulted from the increased mitochondrial damages of Drp1-knockdown cells. 
Notably, enhanced extracellular signal-regulated kinase (ERK) signaling in Drp1-knockdown 
macrophages is implicated in the potentiation of NLRP3 inflammasome activation, possibly via 
mediating mitochondrial localization of NLRP3 to facilitate the assembly of NLRP3 inflammasome. 
Taken together, our results provide a molecular insight into the importance of mitochondrial 
dynamics in potentiating NLRP3 inflammasome activation, leading to aberrant inflammation.
Inflammasomes are caspase-1-activating multi-protein complex, comprised of sensor protein such as 
NOD-like receptor family, pyrin domain-containing 3 (NLRP3) or NLR family, CARD-containing 4 
(NLRC4), adaptor protein apoptosis-associated speck-like protein containing a caspase-recruitment 
domain (ASC) and effector protein procaspase-11. The assembly of inflammasome components upon 
sensing of microbial infection or tissue injury mediates caspase-1-dependent processing and secretion 
of interleukin (IL)-1β or IL-18 to provide host innate immune protection1,2. Despite the fact that dereg-
ulated NLRP3 inflammasome activation potentially contributes to the pathogenesis of chronic inflamma-
tory or metabolic disorders such as type 2 diabetes and Alzheimer’s disease3,4, the underlying mechanism 
by which NLRP3 inflammasome signaling is initiated or potentiated remains still elusive.
The role of mitochondria in regulating the activation of the NLRP3 inflammasome has garnered 
much interest5,6. The accumulation of damaged mitochondria might trigger the activation of the NLRP3 
inflammasome by releasing mitochondrial reactive oxygen species (mROS) or mitochondrial DNA 
(mtDNA) into the cytosol5,7. Moreover, mitochondria could serve as a molecular platform for the NLRP3 
inflammasome in specific cellular contexts; for instance, mitochondrial outer membrane proteins such 
as mitochondrial anti-viral signaling protein (MAVS) or mitofusin 2 (Mfn2) could recruit NLRP3 to 
assemble the inflammasome complex in response to viral infection8–10.
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Mitochondria are dynamic organelles that continuously fuse and divide to control their size, mor-
phology, mtDNA integrity, and cellular redox state11. Mitochondrial dynamics are well-balanced with 
mitochondrial biogenesis and degradation (mitophagy) to maintain mitochondrial homeostasis12. The 
regulation of mitochondrial dynamics is controlled by specific proteins for mitochondrial fission or 
fusion, such as dynamin-related protein 1 (Drp1) and fission protein 1 (Fis1) for fission, and Mfn1, 
Mfn2, and optic atrophy gene 1 (Opa1) for fusion12. An imbalance in mitochondrial dynamics, caused 
by loss-of-function mutations in proteins that make up the mitochondrial fission and fusion machinery, 
not only results in the impairment of mitochondrial or cellular functions such as energy production, 
mtDNA integrity, and cell proliferation, but also causes many complex disorders including Parkinson’s 
or Alzheimer’s disease11,12.
The role of mitochondrial dynamics in the regulation of innate immune responses was recently dis-
covered: through its association with MAVS, Mfn2 interferes with MAVS-mediated anti-viral signaling 
in response to viral infection13. Other studies, on the contrary, revealed that mitochondrial elongation 
is required for MAVS signaling in an Mfn1-dependent manner14,15. These findings indicate that mito-
chondrial fusion facilitates type I interferon (IFN) production in response to virus infection. However, 
the putative role of mitochondrial dynamics in inflammasome signaling remains poorly described. 
Intriguingly, elongated mitochondria, formed by a failure of Drp1 to localize into mitochondria or by 
decreased Drp1 expression in the Alzheimer’s disease patients, accumulated in the perinuclear region16,17, 
where the indications of NLRP3 inflammasome assembly including ASC speck-like aggregates and asso-
ciation between NLRP3 and ASC have also been observed18–20. We therefore attempted to investigate 
whether altered mitochondrial dynamics due to knockdown of Drp1 could modulate the assembly and 
activation of the NLRP3 inflammasome.
Results
Knockdown of Drp1 leads to mitochondrial elongation and increases susceptibility to 
caspase-1-dependent cell death. To generate macrophages with stable knockdown of Drp1, len-
tiviral particles expressing non-targeting (scrambled) or Drp1-targeting short hairpin RNA (shRNA) 
were used to infect mouse bone marrow-derived macrophages (BMDMs). Drp1 expression was largely 
abolished in the selected clones of shDrp1 BMDMs (Fig.  1a). As expected, mitochondria from Drp1-
knockdown macrophages displayed an elongated or enlarged shape as observed by confocal and trans-
mission electron microscopy (Fig.  1b,c). Because mitochondria play an important role in regulating 
programmed cell death, we first determined the sensitivity of both macrophages to apoptotic, necrop-
totic, or pyroptotic cell death stimulation. In agreement with previous reports, shDrp1 cells containing 
elongated mitochondria exhibited significantly decreased apoptosis and caspase-3 processing compared 
to shScr BMDMs upon TNF-α -cycloheximide (TC) stimulation (Fig.  1d)21,22. On the contrary, both 
types of macrophages exhibited similar RIP-3-dependent necroptosis in response to TNF-α -cyclohex-
imide-zVAD (TCZ) stimulation (Fig.  1d). The requirement of Drp1 for necroptosis is still controver-
sial23,24; the precise role of Drp1 in necroptosis remains to be clarified.
Of more interest, NLRP3 inflammasome-mediated pyroptotic cell death was significantly higher in 
shDrp1 BMDMs than in control BMDMs upon NLRP3-activating LPS/ATP or LPS/nigericin stimu-
lation (Fig.  1e). Supporting this data, Drp1-knockdown BMDMs showed a potentiated cell death 
upon ATP or nigericin stimulation, but a decreased cell death upon TC stimulation, as determined 
by propidium iodide (PI) staining (Supplementary Fig. S1a). In addition, TC-induced apoptosis was 
decreased in Drp1-knockdown BMDMs (Supplementary Fig. S1b). Similar to the previous reports25,26, 
LPS/nigericin stimulation caused a NLRP3-dependent cell death (Supplementary Fig. S1c), and ATP- 
or nigericin-triggered cell death was significantly attenuated by YVAD, a specific caspase-1 inhibitor 
(Supplementary Fig. S1d and S1e). These findings raise the possibility that caspase-1/inflammasome 
signaling might be more potent in shDrp1 BMDMs containing elongated mitochondria than in shScr 
BMDMs.
Mitochondrial elongation, but not fission, potentiates NLRP3 inflammasome activation. We 
next examined whether mitochondrial elongation indeed affects the NLRP3-dependent activation of 
caspase-1. In LPS-primed BMDMs, the knockdown of Drp1 induced much stronger caspase-1 pro-
cessing in response to ATP stimulation (Fig.  2a and Supplementary Fig. S2). Supporting this finding, 
IL-1β secretion was also remarkably increased in Drp1-knockdown macrophages upon LPS/ATP or 
LPS/nigericin stimulation (Fig.  2b). Notably, only ATP or nigericin stimulation (signal 2) without LPS 
priming (signal 1) is sufficient to activate caspase-1 activation in Drp1-knockdown BMDMs, but not in 
shScr BMDMs (Fig. 2a,c). Furthermore, specific inhibition of Drp1 by mitochondrial division inhibitor-1 
(mdivi-1) also consistently potentiated LPS/ATP- or ATP-mediated caspase-1 activation in wild-type 
BMDMs (Fig. 2d). To validate this finding, we checked the role of altered mitochondrial dynamics for the 
inflammasome activity in human monocytic THP-1 cells stably expressing non-targeting, Drp1-targeting 
or Opa1-targeting shRNA. Supporting above-mentioned results in mouse BMDMs, both caspase-1 
activation and IL-1β secretion was markedly increased in Drp1-knockdown THP-1 cells, but not in 
Opa1-knockdown cells, compared to control scrambled cells in response to LPS or Alum stimulation 
(Fig.  2e). On the other hand, the NLRC4-dependent caspase-1 activation by Salmonella infection was 
not considerably affected by the knockdown of Drp1 in macrophages (Fig. 2f).
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To examine whether the potentiated NLRP3 inflammasome activation in Drp1-knockdown mac-
rophages is due to an increase in the transcriptional induction of NLRP3, we determined the mRNA 
levels of Nlrp3 upon LPS stimulation. Consequently, Drp1-knockdown cells exhibited no significant dif-
ference in the mRNA production of Nlrp3 compared to control scrambled macrophages in response to 
LPS stimulation (Fig. 3a).
The protonophore carbonyl cyanide m-chlorophenyl hydrazone (CCCP) has been shown to induce 
mitochondrial fission or fragmentation in a Drp1-dependent manner27. Supporting our data, CCCP treat-
ment largely impaired caspase-1 activation in LPS/ATP or LPS/nigericin-stimulated BMDMs (Fig. 3b). 
To examine whether CCCP-induced attenuation of caspase-1 activation stems from the reduction in the 
expression of NLRP3, we performed a similar experiment in NLRP3-reconstituted macrophages (N1–8) 
in which NLRP3 expression is not regulated by TLR-NF-κ B signaling28. Consistently, CCCP abolished 
LPS/nigericin-triggered caspase-1 activation in NLRP3-stably expressing macrophages (Fig. 3c), demon-
strating that CCCP-mediated inhibition of NLRP3 inflammasome is not resulted from the reduced 
NLRP3 expression. Contrary to our data, previous studies demonstrated that CCCP promotes IL-1β 
secretion possibly via the production of mROS5,29. However, CCCP did not induce mROS production in 
our experiment (Supplementary Fig. S3).
Mitochondrial uncoupler CCCP was also reported to induce parkin-mediated mitophagy30. We 
thus examined the inhibitory effect of CCCP on the NLRP3 inflammasome in Atg5-deficient BMDMs 
Figure 1. Knockdown of Drp1 leads to mitochondrial elongation and increases pyroptotic cell death of 
macrophages. (a) Expression levels of Drp1 in wild-type mouse BMDMs and scrambled shRNA- (Scr) or 
Drp1-specific shRNA-expressing (Drp1) BMDMs. (b) Confocal images of shScr or shDrp1 BMDMs stained 
with MitoTracker Red. The blue signal represents nuclear fluorescence. Scale bars, 5 μ m. (c) Transmission 
electron microscopy (TEM) images of shScr or shDrp1 BMDMs. Scale bars, 2 μ m. Magnification, 20,000× . 
(d,e) ShScr or shDrp1 BMDMs were stimulated with TNF-α and CHX in the absence (TC) or presence 
(TCZ) of zVAD-fmk, or primed with LPS, followed by ATP (L + A) or nigericin (L + N) treatment. Cells 
were then assayed for LDH release and cellular lysates were immunoblotted with the indicated antibodies. 
Asterisks indicate significant differences (n = 6, *p< 0.0005, d; n = 6, *p < 0.0005, **p < 0.0001, e).
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Figure 2. Mitochondrial elongation potentiates NLRP3 inflammasome activation. (a) ShScr or shDrp1 
BMDMs were primed with LPS, followed by ATP (1 or 2.5 mM) treatment as indicated. (b) ShScr or 
shDrp1 BMDMs were primed with LPS, followed by ATP (2.5 mM) or nigericin (5 μ M) treatment. Culture 
supernatants were assayed for extracellular IL-1β by ELISA. Asterisks indicate significant differences (n = 3, 
*p < 0.05, **p < 0.005). (c) ShScr or shDrp1 BMDMs were untreated or treated with ATP (2.5 mM, 40 min) 
in the presence or absence of LPS priming, or treated with nigericin (5 μ M, 40 min). (d) Wild-type BMDMs 
were untreated or treated with LPS in the presence or absence of mdivi-1 (25 μ M) pretreatment, followed 
with ATP treatment. (e) PMA-differentiated shScr, shDrp1 or shOpa1 THP-1 cells were stimulated with 
LPS or Alum. (f) ShScr or shDrp1 BMDMs were untreated, infected with S. typhimurium (Sal, MOI 20) as 
described in Methods or treated with LPS, followed by ATP as in (c). (a,c–f) Culture supernatants (Sup) and 
cellular lysates (Lys) were immunoblotted with the indicated antibodies.
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to determine the possibility that mitophagy could mediate the CCCP-induced inhibition. However, 
CCCP-induced inhibition of caspase-1 activation by LPS/ATP was also evident in Atg5−/− BMDMs 
(Fig. 3d). These data suggest that CCCP-induced mitochondrial fission or fragmentation does not pro-
mote but suppress NLRP3 inflammasome activation in a mitophagy-independent manner.
Mitochondrial elongation potentiates NLRP3 inflammasome assembly. We, next, examined 
the role of mitochondrial dynamics in the assembly of the NLRP3 inflammasome as determined by 
NLRP3-ASC interaction and ASC oligomerization. Both events are essential and prerequisite steps for 
the activation of NLRP3 inflammasome18,31. LPS priming substantially promoted the association of 
NLRP3 with ASC, but the NLRP3-ASC interaction was much stronger in Drp1-knockdown BMDMs 
(Fig. 4a). In a similar manner, ASC oligomerization, triggered by LPS/nigericin or LPS/ATP stimulation, 
was much more potent in shDrp1 BMDMs than in shScr BMDMs (Fig. 4b,c). On the contrary, CCCP 
treatment to induce mitochondrial fission considerably attenuated the NLRP3-ASC interaction and ASC 
oligomerization (Fig. 4d,e). These findings indicate that mitochondrial elongation by Drp1 knockdown 
facilitates the NLRP3-ASC association and the subsequent ASC oligomerization, although the underly-
ing mechanism by which mitochondrial elongation controls the assembly of the NLRP3 inflammasome 
remains uncertain.
Augmented NLRP3 inflammasome activation in Drp1-knockdown macrophages is inde-
pendent of the increased mitochondrial damages. To provide molecular insights into how 
Figure 3. CCCP attenuates NLRP3 inflammasome activation. (a) ShScr or shDrp1 BMDMs were treated 
with LPS (0.5 μ g/ml, 3 h), and mRNA production was determined by quantitative real-time PCR as described 
in Methods (n = 3). (b) Wild-type BMDMs were treated with LPS in the presence of CCCP (1–40 μ M, left 
panel; 20 μ M, right panel), followed by ATP (left) or nigericin (right) treatment. (c) Immortalized NLRP3-
reconstituted macrophages (N1–8) were unprimed or primed with LPS (30 min or 120 min) in the presence 
of CCCP (20 μ M), followed by nigericin treatment as indicated. (d) Wild-type or Atg5-deficient BMDMs 
were treated with LPS in the presence of CCCP (5 or 10 μ M) pretreatment as indicated, followed with 
ATP treatment. (b–d) Culture supernatants (Sup) and cellular lysates (Lys) were immunoblotted with the 
indicated antibodies.
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mitochondrial elongation potentiates the activation of the NLRP3 inflammasome, we determined the 
generation of mitochondria-derived products such as mROS and mtDNA in both types of BMDMs. 
LPS/ATP stimulation caused a substantial increase in mROS-producing mitochondria, as indicated by 
mROS-sensitive MitoSOX staining (Fig.  5a). Upon LPS/ATP stimulation, Drp1-knockdown BMDMs 
exhibited slightly elevated mROS production compared to shScr BMDMs (Fig.  5a). However, LPS/
ATP-mediated mROS production was partially impaired by the absence of NLRP3 or by the presence 
of the pan-caspase inhibitor zVAD (Fig. 5b). Furthermore, a selective caspase-1 inhibitor YVAD signif-
icantly reduced mROS production by LPS/ATP stimulation (Fig. 5c and Supplementary Fig. S4). In this 
regard, we cannot exclude the possibility that the increased mROS production reflects, at least in part, 
the augmented caspase-1 activation in Drp1-knockdown macrophages.
ATP stimulation of LPS-primed BMDMs caused a robust release of mtDNA into the cytosol (Fig. 5d). 
Of note, mtDNA release was slightly but significantly higher in shDrp1 BMDMs than in shScr BMDMs, 
especially at 15 min of ATP stimulation. However, LPS/ATP-induced cytoplasmic release of mtDNA was 
completely abolished in Nlrp3−/− BMDMs (Fig.  5e), indicating that mtDNA release might depend on 
caspase-1 activation or the presence of NLRP3, as previously suggested7. This finding led us to infer that 
the increased mtDNA release is not responsible for the stronger caspase-1 activation in Drp1-knockdown 
BMDMs. Indeed, the inhibition of caspase-1 by YVAD largely abolished LPS/ATP-promoted mtDNA 
release (Fig. 5f).
To provide more evidence whether the increased mitochondrial damage contributes into the poten-
tiated NLRP3 inflammasome activation in Drp1-knockdown cells, we determined another indication 
of mitochondrial damage by costaining the cells with MitoTracker Green and MitoTracker Deep Red 
to measure the dissipation of mitochondrial membrane potential. As expected, LPS/ATP stimulation 
caused a substantial increase in the damaged mitochondria-containing cell population as indicated by the 
Figure 4. Mitochondrial elongation facilitates the assembly of the NLRP3 inflammasome. (a) ShScr or 
shDrp1 BMDMs were untreated or treated with LPS, followed with ATP (2.5 mM, 30 min) as indicated. 
Soluble lysates were immunoprecipitated with anti-ASC antibody, and the immunoprecipitates or lysates 
were immunoblotted with the indicated antibodies. (b,c) ShScr or shDrp1 BMDMs were untreated or treated 
with LPS, followed by treatment with nigericin (45 min or 120 min, (b)) or ATP (2 mM, 45 min, (c)). ASC 
oligomeric structures were assayed by DSS-mediated cross-linking. (d,e) Wild-type BMDMs were untreated 
or treated with LPS in the presence or absence of CCCP (5 μ M) for 3 h, followed by ATP or nigericin as 
indicated. NLRP3-ASC association (d) and ASC oligomerization (e) were assayed as described in (a) and 
(b).
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reduction of MitoTracker Deep Red signal (Fig. 6a). Indeed, LPS/ATP-mediated mitochondrial damage 
was significantly higher in shDrp1 BMDMs than in shScr cells (Fig.  6b). However, in agreement with 
a recent report32, LPS/ATP-induced mitochondrial damage was largely impaired in Nlrp3−/− BMDMs 
(Fig.  6c,d). This finding also supports the idea that increased mitochondrial damage, as well as the 
presence of mtDNA, might not be a main contributor to potentiating NLRP3 inflammasome activation, 
but rather a consequence of augmented caspase-1 activation in shDrp1 cells. Therefore, we reasoned 
that some mechanistic basis other than that of increased mitochondrial damage is required to potentiate 
NLRP3 inflammasome activation in Drp1-knockdown macrophages.
Figure 5. Drp1-knockdown BMDMs exhibit increased mROS production and mtDNA release. (a) 
Scrambled or Drp1-knockdown BMDMs were untreated or treated with LPS, followed by treatment with 
ATP (2.5 mM, 30 min). (b) Wild-type or Nlrp3−/− BMDMs were untreated or treated with LPS (0.25 μ g/ml,  
2 h) in the presence or absence of zVAD-fmk (20 μ M, 30 min pretreatment before LPS) as indicated, followed 
with ATP. (a,b) Cells were stained with MitoSOX and analyzed by flow cytometry. (c) ShDrp1 BMDMs 
were primed with LPS in the presence or absence of YVAD-cmk, followed by treatment with ATP. Cells 
were stained with MitoSOX and analyzed by flow cytometry. MitoSOX-positive cells were plotted. Asterisk 
indicates a significant difference (n = 4, *p < 0.01). (d,e) Scrambled or Drp1-knockdown BMDMs (d) and 
wild-type or Nlrp3−/− BMDMs (e) were primed with LPS, followed by treatment with ATP (15 or 30 min, 
(d) 30 min, (e)) as indicated. Cytosolic mtDNA was quantified as described in Methods. Asterisks indicate 
significant differences (n = 3, *p < 0.05). (f) ShDrp1 BMDMs were primed with LPS in the presence or 
absence of YVAD-cmk, followed by treatment with ATP. Cytosolic mtDNA was then assayed. Asterisk 
indicates a significant difference in comparison to LPS/ATP-treated samples (n = 3, *p < 0.0001).
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Knockdown of Drp1 induces constitutive activation of ERK to facilitate the assembly of the 
NLRP3 inflammasome. Recently, it was proposed that extracellular signal-regulated kinase (ERK) 
signaling is implicated in the LPS-induced priming of NLRP3, required for inflammasome activa-
tion33. Indeed, inhibition of the ERK pathway by U0126, a selective inhibitor of MEK1 and MEK2, 
markedly diminished ATP- or nigericin-mediated caspase-1 activation in wild-type BMDMs (Fig.  7a). 
Interestingly, mitochondrial localization of ERK and its upstream MAPK/ERK kinase (MEK) was pre-
viously reported34,35. We thus test whether ERK signaling might be implicated in augmented NLRP3 
inflammasome activation in Drp1-knockdown macrophages.
LPS stimulation caused robust ERK1 and ERK2 phosphorylation in shScr BMDMs (Fig.  7b). 
Intriguingly, Drp1-knockdown BMDMs displayed a constitutive basal phosphorylation of ERK, but 
not of c-Jun N-terminal kinase (JNK), even without LPS stimulation (Fig.  7b). Supporting this obser-
vation, CCCP attenuated LPS- or LPS/ATP-mediated ERK phosphorylation (Supplementary Fig. S5). 
ERK phosphorylation in shDrp1 BMDMs was also attenuated by U0126 (Fig. 7c), and U0126 treatment 
significantly inhibited LPS/ATP-mediated caspase-1 activation and IL-1β secretion in shDrp1 BMDMs 
(Fig. 7c,d). These observations demonstrate that ERK signaling is implicated in the augmented NLRP3 
inflammasome activation seen in Drp1-knockdown macrophages.
Because mitochondria could serve as a platform to assemble inflammasome components5,8–10, we 
assessed the subcellular distribution of NLRP3 inflammasome components. In shScr BMDMs, LPS prim-
ing increased mitochondrial distribution of NLRP3, which is inhibited by U0126 (Fig. 7e). Furthermore, 
the association of NLRP3 with ASC was also partially attenuated by U0126 treatment (Fig.  7f), indi-
cating that ERK-dependent mitochondrial localization of NLRP3 is important for the assembly of the 
NLRP3 inflammasome. Consistent with this, in addition to ERK phosphorylation, the basal mitochon-
drial localization of NLRP3 was increased in unstimulated shDrp1 cells compared to shScr cells (Fig. 7e). 
Unexpectedly, ASC levels in mitochondria were also higher in shDrp1 cells to provide a more favorable 
cellular context for the assembly of the NLRP3 inflammasome. Collectively, our data present evidence 
Figure 6. Mitochondrial damage reflects inflammasome activation. ShScr or shDrp1 BMDMs (a,b) 
and wild-type or Nlrp3−/− BMDMs (c,d) were untreated or treated with LPS, followed with ATP (2.5 mM, 
30 min). Cells were costained with MitoTracker Green and MitoTracker Deep Red, and then analyzed by 
flow cytometer. Representative histograms of four- or three-independent experiments were presented as 
in (a) and (c). (b,d) Relative cell populations inside the box from independent experiments were plotted. 
Asterisk indicates a significant difference (n = 4, *p < 0.01, b; n = 3, *p < 0.05, d).
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Figure 7. Mitochondrial elongation potentiates NLRP3 inflammasome in an ERK-dependent manner. 
(a) Wild-type BMDMs were untreated or treated with LPS in the presence or absence of U0126 (10 μ M, 
30 min pretreatment before LPS), followed with ATP or nigericin treatment as indicated. (b) ShScr or shDrp1 
BMDMs were untreated or treated with LPS, followed by ATP (2.5 mM, 10 min or 30 min) treatments as 
indicated. (c,d) ShScr or shDrp1 BMDMs were untreated or treated with LPS in the presence or absence of 
U0126 (10 μ M, 30 min or 120 min (c) or 30 min (d) pretreatment), followed by treatment with ATP. (d) Culture 
supernatants were assayed for extracellular IL-1β by ELISA. Asterisks indicate significant difference from LPS/
ATP-only treated samples in shScr or shDrp1 cells (n = 3, *p < 0.005). (e) ShScr or shDrp1 BMDMs were 
untreated or treated with LPS in the presence or absence of U0126 pretreatment (10 μ M, 2 h). Cellular lysates 
were fractionated into mitochondria-enriched (Mito) or cytosolic (Cyt) fractions, and each of the fractionated 
samples was immunoblotted. (f) Wild-type BMDMs were untreated or treated with LPS in the presence of 
U0126 pretreatment (10 μ M, 30 min), followed by treatment with ATP. Soluble lysates were immunoprecipitated 
with the anti-ASC antibody, and the immunoprecipitates or lysates were immunoblotted.
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that mitochondrial elongation induces the activation of the ERK pathway, which is important for the 
recruitment of NLRP3 into mitochondria, and this, in turn, facilitates the assembly and activation of the 
NLRP3 inflammasome.
Discussion
Mitochondrial dynamics play an important role in maintaining the size, number, and integrity of mito-
chondria during cell division36. Genetic ablations or mutations in the mitochondrial dynamics machin-
ery have shown severe defects in brain development or embryonic lethality12,27. Of particular interest, a 
loss-of-function mutation in Drp1 or a failure of Drp1 to locate into mitochondria causes mitochondrial 
elongation, resulting in the defective brain development, optic atrophy and neurodegeneration16,37,38. 
Supporting this, fibroblasts from Alzheimer’s disease patients showed a significant decrease in Drp1 
expression and consequently hyperfused mitochondria17. Considering that inflammasome-mediated 
neuroinflammation significantly contributes to the pathogenesis of neurodegenerative diseases like 
Alzheimer’s disease39, it is of great significance to decipher the role of Drp1-mediated defective mito-
chondrial dynamics in inflammasome signaling.
In addition to generating cellular energy, mitochondria participate in several intracellular signaling 
pathways such as apoptosis and anti-viral responses40. Furthermore, recent studies proposed that indica-
tors of mitochondrial damage such as mROS production, cytosolic release of mtDNA, and the dissipation 
of mitochondrial membrane potential are crucial common factors for triggering NLRP3 inflammas-
ome activation5,7. Our data also show that Drp1-knockdown macrophages generated increased levels of 
mitochondrial damage-associated indicators under NLRP3-stimulating condition. However, these indi-
cations were, at least in part, caspase-1 activation-dependent, and could be potentiated by caspase-1/
inflammasome activation (Figs  5 and 6). We therefore inferred that increased mitochondrial damage 
does not fully explain the augmented caspase-1 activation in Drp1-knockdown macrophages. In support 
of this idea, sustained LPS/nigericin stimulation caused robust mitochondrial fragmentation in scram-
bled and Drp1-knockdown BMDMs (Fig.  8a), indicating that mitochondrial fragmentation might be 
the consequence of caspase-1 activation. Furthermore, YVAD, a selective caspase-1 inhibitor, clearly 
prevented mitochondrial fragmentation induced by LPS/ATP or LPS/nigericin stimulation (Fig. 8b and 
Supplementary Fig. S6). In addition, CCCP treatment to induce mitochondrial fission or fragmenta-
tion efficiently abolished NLRP3-dependent caspase-1 activation and NLRP3 inflammasome assem-
bly in our data (Figs  3 and 4). Although CCCP was previously shown to promote or inhibit NLRP3 
inflammasome5,10, our data emphasizes that CCCP-mediated mitochondrial fission or fragmentation 
appears to attenuate the assembly and the activation of NLRP3 inflammasome in a transcription- or 
mitophagy-independent manner.
The role of mitochondrial dynamics in inflammasome signaling has not been much explored until 
recently. Ichinohe et al. first demonstrated that Mfn2 is required for the full activation of NLRP3 inflam-
masome through the formation of the NLRP3-Mfn2-MAVS complex upon RNA virus infection10, sug-
gesting that mitochondrial fusion is favorable to NLRP3 inflammasome assembly. In contrast, Wang et al.  
recently showed that RNA viral infection promotes the assembly of the RIP1-RIP3 complex, which 
phosphorylates Drp1, leading to mitochondrial fission and the subsequent activation of the NLRP3 
inflammasome29. This study proposed that Drp1-mediated mitochondrial fission increases mitochon-
drial damage, resulting in the activation of the NLRP3 inflammasome upon viral infection. These recent 
findings are contradictory in terms of the role of mitochondrial dynamics on the viral RNA-mediated 
NLRP3 inflammasome, but our study results show that Drp1-knockdown cells containing elongated 
mitochondria induce augmented NLRP3 activation in response to classical ATP or nigericin stimulation.
Interestingly, a previous report also demonstrated that Drp1 deficiency had no effect on the IL-1β 
secretion of BMDMs in response to LPS/ATP or LPS/nigericin stimulation29. They suggested that ATP or 
nigericin promoted mROS production or mitochondrial damages in a Drp1-independent manner. In this 
regard, ATP- or nigericin-induced NLRP3 inflammasome activation is independent of Drp1 presence. 
However, our results showed that augmented NLRP3 inflammasome activation by Drp1 knockdown 
might be explained by the increased association of inflammasome components, rather than by the pro-
duction of mROS or mitochondrial damages. Furthermore, our data strongly suggest that mitochondrial 
elongation provides a favorable cellular context for NLRP3 activation, while mitochondrial fission or 
fragmentation is rather a consequence of inflammasome activation.
Our data also present that the ERK pathway is a critical priming event for the activation of NLRP3 
inflammasome. We revealed that enhanced ERK signaling mediates the recruitment of NLRP3 into 
mitochondria, facilitating the assembly of the NLRP3 inflammasome in Drp1-knockdown macrophages. 
Although the question of how mitochondrial elongation induces ERK activation requires more clarifica-
tion, the ERK pathway could be an effective target to alleviate excessive NLRP3 inflammasome activation 
resulting from aberrant mitochondrial elongation. In conclusion, our data demonstrate that mitochon-
drial elongation caused by the decreased expression of the fission protein Drp1 creates a favorable cel-
lular context for NLRP3 inflammasome activation in an ERK-dependent manner, thereby leading to 
diseases associated with deregulated inflammation.
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Methods
Reagents and antibodies. LPS, ATP, nigericin, cycloheximide (CHX), CCCP, mdivi-1, propidium 
iodide (PI), U0126, and Drp1-targeting or non-targeting shRNA lentiviral plasmids were purchased 
from Sigma. Alum was purchased from InvivoGen. Ac-YVAD-chloromethylketone (Ac-YVAD-cmk) 
and z-VAD-fluoromethylketone (zVAD-fmk) were obtained from Bachem. Mouse IL-1β enzyme-linked 
Figure 8. Mitochondrial fragmentation induced by NLRP3 inflammasome activation. (a) Confocal 
images of shScr or shDrp1 BMDMs left untreated or treated with LPS (0.25 μ g/ml, 3 h), followed with 
nigericin (5 μ M, 1 h) stimulation. Immunofluorescence assays were performed using anti-Tom20 antibody 
(red) and anti-NLRP3 antibody (green). (b) ShScr or ShDrp1 BMDMs were primed with LPS in the 
presence of YVAD (20 μ M), followed by ATP (2 mM, 45 min) or nigericin (5 μ M, 45 min) treatment. Cells 
were stained with anti-Tom20 antibody (red) and analyzed by confocal microscopy as in (a). (a,b) Blue 
signal represents nuclear fluorescence. Scale bars, 10 μ m.
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immunoassay (ELISA) kits were obtained from R&D. MitoSOX, MitoTracker Green, MitoTracker Deep 
Red, and mouse recombinant TNF-α were purchased from Invitrogen. Annexin V-FITC apoptosis detec-
tion kit was obtained from BD Bioscience. Anti-human caspase-1 (p10), anti-ASC, anti-phospho-ERK 
and anti-β -actin antibodies were purchased from Santa Cruz. Anti-mouse IL-1β antibody was obtained 
from R&D. Anti-mouse caspase-1 (p20) and anti-NLRP3 antibodies were from Adipogen. Anti-Drp1 
and anti-JNK1/2 antibody were purchased from BD Biosciences. Anti-phospho-JNK1/2 antibody was 
obtained from Invitrogen. Anti-VDAC1 antibody was obtained from Abcam. All other antibodies detect-
ing human IL-1β , caspase-3, ERK, and Iκ B were obtained from Cell Signaling.
Cell culture. Mouse bone marrow-derived macrophages (BMDMs) were prepared from C57BL/6, 
Nlrp3−/− or Atg5−/− mice as described previously41. All mice were maintained under specific pathogen-free 
conditions. Protocols for the animal experiments were approved by the Institutional Ethical Committee, 
Yonsei University College of Medicine. All the experiments involving BMDM preparation were per-
formed in accordance with the approved guidelines of the Institutional Ethical Committee. Immortalized 
NLRP3-reconstituted BMDMs (N1–8) were kindly provided by Dr. E. S. Alnemri (Thomas Jefferson 
University). To knockdown Drp1 expression, we used lentiviral particles containing non-targeting 
(scrambled) or targeting Drp1 shRNA to infect mouse BMDMs. Cells stably expressing shRNA were 
then cloned by puromycin selection. All BMDMs were maintained in L929-conditioned DMEM supple-
mented with 10% FBS and 100 U/ml penicillin/streptomycin. THP-1 cells were cultured in RPMI1640 
supplemented with 10% FBS, 2 mM glutamine, 10 mM HEPES, 1 mM sodium pyruvate, 0.05 mM 2-ME 
and 100 U/ml penicillin/streptomycin. To knockdown Drp1 or Opa1 expression, lentiviral particles con-
taining non-targeting, Drp1-targeting or Opa1-targeting shRNA were used to infect THP-1 cells.
Determination of cell death. To induce apoptotic, necroptotic, or pyroptotic cell death, cells were 
treated with TNF-α (30 ng/ml) and cycloheximide (CHX, 0.4 μ g/ml) with or without zVAD-fmk (20 μ M) 
for 20 h, or cells were primed with LPS (0.25 μ g/ml, 2 h), followed by treatment with nigericin (5 μ M, 
45 min). Cell death was then determined by the extracellular release of lactate dehydrogenase (LDH) 
using a CytoTox96 non-radioactive cytotoxicity assay kit (Promega). LDH release was calculated as 
[extracellular LDH/(intracellular LDH + extracellular LDH) × 100].
Immunoblot analysis. Immunoblotting, co-immunoprecipitation and subcellular fractionation 
experiments were performed as described previously8. All the immunoblots are representative images of 
at least three independent experiments.
Observation of mitochondrial morphology. For confocal microscopy, cells were stained with 
MitoTracker Red (Invitrogen) and Hoechst 33258 (Sigma) according to the manufacturer’s protocol, and 
examined using a confocal microscope (LSM700, Carl Zeiss). In some experiments, immunofluorescence 
assays were performed using anti-Tom 20 antibody to observe mitochondria as described previously20. 
For transmission electron microscopy (TEM), cells were fixed with 2% glutaraldehyde-paraformaldehyde 
in 0.1 M phosphate buffer, pH 7.4, for 2 h. After washing, cells were post-fixed with 1% OsO4 in 0.1 M 
phosphate buffer for 2 h and dehydrated in ascending gradual series (50~100%) of ethanol. Specimens 
were embedded using a Poly/Bed 812 kit (Polysciences, Inc.). Seventy-nanometer-thin sections were 
stained with uranyl acetate and lead citrate. Stained sections were then observed using a JEM-1011 
(JEOL) transmission electron microscope.
Assay of NLRP3 inflammasome activation. Mouse BMDMs were primed with LPS (0.25 μ g/ml) for 
3 h, followed with ATP (1–2.5 mM, 30–40 min) or nigericin (2.5 μ M, 40 min) treatment. THP-1 cells were 
differentiated with PMA (0.4 mM) for 3 h, and the next day cells were stimulated with LPS (0.5 μ g/ml) 
or Alum (250 μ g/ml) for 6 h. The culture supernatants were precipitated as described previously42, and 
were then immunoblotted with anti-caspase-1 or IL-1β antibody, or assayed for extracellular IL-1β using 
ELISA. To check the oligomerization of ASC, chemical cross-linking was performed using disuccinim-
idyl suberate (DSS), according to previously described methods43.
Quantification of mRNA production. To measure mRNA production, total cellular RNA was iso-
lated using the TRIzol reagent (Invitrogen) and reverse transcribed using PrimeScript™ RT Master Mix 
(Takara) according to the manufacturer’s instructions. Template DNA was amplified by quantitative 
real-time PCR using SYBR Premix Ex Taq™ II (Takara). Primers were as follows: 5′ -ATG CTG CTT 
CGA CAT CTC CT-3′ and 5′ -AAC CAA TGC GAG ATC CTG AC-3′ . (Nlrp3); 5′ -AAC TTT GGC ATT 
GTG GAA GG-3′ and 5′ -ACA CAT TGG GGG TAG GAA CA-3 (GAPDH).
Salmonella infection. S. typhimurium (kindly gifted from Dr. Yoon SS, Yonsei University College of 
Medicine) were grown overnight at 37 °C with aeration, and then diluted (1:20) and grown for additional 
2 h. BMDMs were infected with S. typhimurium at the indicated MOI (multiplicity of infection) for 30 min, 
washed three times to remove extracellular bacteria, and incubated with the gentamicin (100 μ g/ml) 
-containing medium for 150 min before harvest.
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Determination of mitochondria-derived products and mitochondrial damage. To deter-
mine mROS production, cells were stained with MitoSOX (Invitrogen) according to the manufacturer’s 
protocol. The fluorescence of the cells was then monitored by flow cytometer (FACSVerse, BD). To 
measure cytosolic mtDNA, cells were lysed using a 21G syringe in NP-40-free buffer A, and cytosolic 
fractions were prepared as described in Subcellular fractionation subsection. Then, DNA was isolated 
from the normalized cytosolic fraction and the copy number of the gene encoding cytochrome c oxidase 
I was determined by quantitative real-time PCR using the following primers as described previously7. 
5′ -GCCCCAGATATAGCATTCCC-3′ (forward) and 5′ -GTTCATCCTGTTCCTGCTCC-3′ (reverse). To 
determine mitochondrial damage, cells were costained with MitoTracker Deep Red and MitoTracker 
Green and then analyzed by flow cytometry. All the flow cytometry data are representative of at least 
three independent experiments.
Statistical analysis. All values were expressed as the mean ± SEM of individual samples or inde-
pendent experiments. Data were analyzed using the Student’s t test, and p values ≤ 0.05 were considered 
significant.
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